Compare ACET & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | CMTL |
|---|---|---|
| Founded | 1947 | 1967 |
| Country | United States | United States |
| Employees | N/A | 1385 |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 162.1M |
| IPO Year | 2017 | 2024 |
| Metric | ACET | CMTL |
|---|---|---|
| Price | $7.70 | $5.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $65.33 | $6.00 |
| AVG Volume (30 Days) | 161.1K | ★ 225.6K |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $499,528,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.19 |
| 52 Week High | $9.05 | $6.21 |
| Indicator | ACET | CMTL |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 44.72 |
| Support Level | $7.70 | $4.86 |
| Resistance Level | $8.46 | $6.15 |
| Average True Range (ATR) | 0.46 | 0.35 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 96.30 | 23.64 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.